Journal of Antimicrobial Chemotherapy logo Oxford University Press logo

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

Publisher: Oxford University Press

Related content
Volume 44, Number 2, August 1999

< previous issue | all issues | next issue >

Editorial. Over-the-counter antibiotics
pp. 149-150(2)
Author: Wood, MJ

Original articles. In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
pp. 179-192(14)
Authors: Candiani, G; Abbondi, M; Borgonovi, M; Romanò, G; Parenti, F

Intracellular activity of trovafloxacin against Staphylococcus aureus
pp. 193-199(7)
Authors: van den Broek, PJ; Koot, TGA; an Strijen, E; Mattie, H

Involvement of calcium inhibitable binding to the cell wall in the fungicidal activity of CAN-296
pp. 217-222(6)
Authors: Ben-Josef, AM; Manavathu, EK; Platt, D; Sobel, JD

In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
pp. 223-228(6)
Authors: Del Poeta, M; Bixel, AS; Barchiesi, F; Tidwell, RR; Boykin, D; Scalise, G; Perfect, JR

Population pharmacokinetics of amikacin in patients with haematological malignancies
pp. 235-242(8)
Authors: Romano, S; de Gatta, MMF; Calvo, MV; Caballero, D; Dominguez-Gil, A; Lanao, JM

Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India
pp. 243-250(8)
Authors: Butler, T; Sridhar, CB; Dagac, MK; Pathak, K; Pandit, RB; Khakhria, R; Potkar, CN; Zelasky, MT; Johnson, RB

The efficacy and safety of quinupristin/dalfopristin for the treatment of infections cause by vancomycin-resistant Enterococcus faecium
pp. 251-261(11)
Authors: Moellering, RC; Linden, PK; Reinhardt, J; Blumberg, EA; Bompart, f; Talbot, GH; Emergency-Use Study Group, Synercid

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
pp. 263-273(11)
Authors: Nichols, RL; Graham, DR; Barriere, SL; Rodgers, A; Wilson, SE; Zervos, M; Dunn, DL; Kreter, B; Skin, Synercid; Structure Infection Group, Skin

Brief reports. Endothelial cell compatibility of clindamycin, gentamicin, ceftriaxone and teicoplanin in Bier's arterial arrest
pp. 275-277(3)
Authors: Vorbach, H; Robibaro, B; Armbruster, C; Atteneder, M; Reiter, M; Hlousek, M; Schaumann, R; Georgopoulos, A

Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae
pp. 279-281(3)
Authors: Randhawa, B; Harris, EB; Prabhakaran, K

In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
pp. 283-286(4)
Authors: Ramos, G; Cuenca-Estrella, M; Monzón, A; Rodríguez-Tudela, JL

Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery
pp. 287-290(4)
Authors: Salminen, U-S; Viljanen, TUT; Valtonen, VV; Ikonen, TEH; Sahlman, AE; Harjula, ALJ

Book reviews
pp. 303-305(3)
Author: Various,

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page